Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment

Corticosteroids (CS) are standard therapy for the treatment of Duchenne's muscular dystrophy (DMD). Even though they decrease inflammation, they have limited efficacy and are associated with significant side effects. There is therefore the need for new protolerogenic treatments to replace CS. D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Ouisse, Laure-Hélène, Remy, Séverine, Lafoux, Aude, Larcher, Thibaut, Tesson, Laurent, Chenouard, Vanessa, Guillonneau, Carole, Brusselle, Lucas, Vimond, Nadège, Rouger, Karl, Péréon, Yann, Chenouard, Alexis, Gras-Le Guen, Christèle, Braudeau, Cécile, Josien, Régis, Huchet, Corinne, Anegon, Ignacio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746111/
https://ncbi.nlm.nih.gov/pubmed/31552055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados